These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18008262)

  • 1. [Hemifacial spasm: over 10 years of treatment with botulinum toxin].
    Pérez-Saldaña MT; Parkhutik V; Boscá-Blasco ME; Claramonte B; Burguera-Hernández JA
    Rev Neurol; 2007 Nov 16-30; 45(10):582-6. PubMed ID: 18008262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of long term treatment of essential blepharospasm and facial hemispasm with botulinum toxin A].
    Ziak P
    Cesk Slov Oftalmol; 2004 Jan; 60(1):37-44. PubMed ID: 15011305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in improvement between patients with idiopathic versus neurovascular hemifacial spasm after botulinum toxin treatment.
    Tunç T; Cavdar L; Karadağ YS; Okuyucu E; Coşkun O; Inan LE
    J Clin Neurosci; 2008 Mar; 15(3):253-6. PubMed ID: 18191574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
    Thussu A; Barman CR; Prabhakar S
    Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blepharospasm and hemifacial spasm: a protocol for titration of botulinum toxin dose to the individual patient and for the management of refractory cases.
    Ortisi E; Henderson HW; Bunce C; Xing W; Collin JR
    Eye (Lond); 2006 Aug; 20(8):916-22. PubMed ID: 16531977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemifacial spasm and its treatment with botulinum toxin].
    Gouider-Khouja N; Turki I; Ben Hamida M; Hentati F
    Tunis Med; 1999 Jan; 77(1):41-4. PubMed ID: 10333697
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
    Badarny S; Susel Z; Honigman S
    Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blepharospasm and hemifacial spasm: long-term treatment with botulinum toxin.
    Gil Polo C; Rodríguez Sanz MF; Berrocal Izquierdo N; Castrillo Sanz A; Gutiérrez Ríos R; Zamora García MI; Mendoza Rodríguez A; Duarte García-Luis J
    Neurologia; 2013 Apr; 28(3):131-6. PubMed ID: 22652139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.
    Hsiung GY; Das SK; Ranawaya R; Lafontaine AL; Suchowersky O
    Mov Disord; 2002 Nov; 17(6):1288-93. PubMed ID: 12465070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term botulinum toxin efficacy, safety, and immunogenicity.
    Mejia NI; Vuong KD; Jankovic J
    Mov Disord; 2005 May; 20(5):592-7. PubMed ID: 15645481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of botulinum toxin injection for achalasia in Thai patients.
    Leelakusolvong S; Sinpeng T; Pongprasobchai S; Tanwandee T; Kachintorn U; Manatsathit S
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S67-72. PubMed ID: 17718248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
    Cillino S; Raimondi G; Guépratte N; Damiani S; Cillino M; Di Pace F; Casuccio A
    Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations.
    Frei K; Truong DD; Dressler D
    Eur J Neurol; 2006 Feb; 13 Suppl 1():30-5. PubMed ID: 16417595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood-onset hemifacial spasm: successful treatment with botulinum toxin.
    Singer C; Papapetropoulos S; Farronay O
    Pediatr Neurol; 2005 Sep; 33(3):220-2. PubMed ID: 16139741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of botulinum toxin type A for the treatment of facial spasm.
    Serrano LA
    Bol Asoc Med P R; 1993; 85(1-3):7-11. PubMed ID: 8060446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical symptoms, diagnosis and treatment of focal dystonias].
    Klivényi P; Vécsei L
    Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30).
    Tan EK; Fook-Chong S; Lum SY; Lim E
    J Neurol Sci; 2004 Apr; 219(1-2):151-5. PubMed ID: 15050451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemifacial spasm treated with botulinum toxin].
    Jedynak CP; Palfi S; Vidailhet M; Kullmann B
    Rev Neurol (Paris); 1993; 149(3):202-6. PubMed ID: 8235213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blepharospasm: treatment with botulinum toxin].
    Barbosa ER; Silva HC; Haddad MS; Bittar MS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.